Sheikh Rezaei, S.; Gleiss, A.; Reichardt, B.; Wolzt, M.
Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017. J. Clin. Med. 2020, 9, 3398.
https://doi.org/10.3390/jcm9113398
AMA Style
Sheikh Rezaei S, Gleiss A, Reichardt B, Wolzt M.
Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017. Journal of Clinical Medicine. 2020; 9(11):3398.
https://doi.org/10.3390/jcm9113398
Chicago/Turabian Style
Sheikh Rezaei, Safoura, Andreas Gleiss, Berthold Reichardt, and Michael Wolzt.
2020. "Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017" Journal of Clinical Medicine 9, no. 11: 3398.
https://doi.org/10.3390/jcm9113398
APA Style
Sheikh Rezaei, S., Gleiss, A., Reichardt, B., & Wolzt, M.
(2020). Use of Clopidogrel, Prasugrel, or Ticagrelor and Patient Outcome after Acute Coronary Syndrome in Austria from 2015 to 2017. Journal of Clinical Medicine, 9(11), 3398.
https://doi.org/10.3390/jcm9113398